Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Gains from Sales and Divestitures: 2010-2025

  • Exponent's Gains from Sales and Divestitures rose 7.38% to $266,859 in Q1 2025 from the same period last year, while for Jan 2025 it was $266,859, marking a year-over-year increase of 7.38%. This contributed to the annual value of $266,859 for FY2025, which is 7.38% up from last year.
  • Exponent's Gains from Sales and Divestitures amounted to $266,859 in Q1 2025, which was up 7.38% from $248,513 recorded in Q4 2023.
  • Over the past 5 years, Exponent's Gains from Sales and Divestitures peaked at $425,983 during Q1 2021, and registered a low of $248,513 during Q4 2023.
  • In the last 2 years, Exponent's Gains from Sales and Divestitures had a median value of $257,686 in 2023 and averaged $257,686.
  • Per our database at Business Quant, Exponent's Gains from Sales and Divestitures dropped by 23.68% in 2021 and then increased by 7.38% in 2025.
  • Exponent's Gains from Sales and Divestitures (Quarterly) stood at $325,095 in 2021, then declined by 3.70% to $313,072 in 2022, then dropped by 20.62% to $248,513 in 2023, then climbed by 7.38% to $266,859 in 2025.
  • Its Gains from Sales and Divestitures stands at $266,859 for Q1 2025, versus $248,513 for Q4 2023 and $313,072 for Q4 2022.